Literature DB >> 6416707

Persistent reduction in left ventricular asynergy in patients with acute myocardial infarction by intravenous infusion of nitroglycerin.

B I Jugdutt, B A Sussex, J W Warnica, R E Rossall.   

Abstract

Intravenous nitroglycerin (NG) infusion in patients with acute myocardial infarction (AMI) has been shown to improve left ventricular function and myocardial perfusion and to decrease ischemic injury and creatine kinase (CK) indexes of infarct size. To determine whether early NG infusions in patients with AMI decreases the extent of left ventricular asynergy, we used two-dimensional echocardiography to measure asynergic segments (akinesis and/or dyskinesis) at four serial short-axis levels from base to apex (mitral, M; chordal, C; midpapillary, MP; low papillary, LP) in 22 patients with a first anterior AMI. Patients were randomized between infusions of NG (n = 11) or 5% dextrose in water (controls, n = 11) within 5.6 hr after the onset of pain. NG infusion rates were titrated to lower mean arterial pressure to an average level of 7% below control (but not below 80 mm Hg) and were maintained at this level for the duration of the infusions (39 hr). After NG, left ventricular function improved as left ventricular filling pressure decreased (p less than .005), and sigma ST on precordial ST segment mapping decreased (p less than .001). These parameters did not change in control subjects. Computed CK infarct size was smaller in the NG group than in the control group (p less than .05). Before the infusions, the mean extent of left ventricular asynergy (% left ventricular circumference) were similar in both groups: M, 18% vs 21%; C, 22% vs 23%; MP, 26% vs 24%; LP, 32% vs 29%. In addition, the computed total left ventricular asynergy (% surface area) was also similar for these two groups before therapy (25% vs 25%). There was no change in left ventricular asynergy from pretreatment values by 1 hr and 10 days among control subjects: M, 18% vs 18% vs 17%; C, 22% vs 22%; MP, 26% vs 26% vs 22%; LP, 32% vs 33% vs 33%; total 25% vs 25% vs 24% (multiple measures analysis of variance). In contrast, there was a significant decrease (p less than .001) in left ventricular asynergy from pretreatment values by 1 hr and 10 days with NG: M, 21% vs 10% vs 8%; C, 23% vs 12% vs 10%; MP, 24% vs 13% vs 9%; LP, 29% vs 14% vs 10%; total, 25% vs 12% vs 9%.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416707     DOI: 10.1161/01.cir.68.6.1264

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Effects of nitrates on mortality in acute myocardial infarction and in heart failure.

Authors:  P Held
Journal:  Br J Clin Pharmacol       Date:  1992       Impact factor: 4.335

Review 2.  Left ventricular dilatation and failure post-myocardial infarction: pathophysiology and possible pharmacologic interventions.

Authors:  B G Firth; P M Dunnmon
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

Review 3.  Nitrate tolerance. A review of the evidence.

Authors:  J T Flaherty
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 4.  Nitrates in acute myocardial infarction.

Authors:  J Kjekshus
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Nitrates in myocardial infarction.

Authors:  B I Jugdutt
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 6.  Use of nitroglycerin for the treatment of acute myocardial infarction.

Authors:  B I Jugdutt
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

Review 7.  Nitric oxide and cardiovascular protection.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

8.  Myocardial infarction: is bepridil, a new calcium antagonist, able to improve the course of the acute phase?

Authors:  D Flammang; M Waynberger; R Paillet; C Pruvot; G Cosson; A Chassing
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

Review 9.  Ulster says 'NO'; explosion, resistance and tolerance. Nitric oxide and the actions of organic nitrates.

Authors:  G D Johnston
Journal:  Ulster Med J       Date:  1998-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.